Oura’s $15.6 Billion IPO Turns Health Data Into a Valuation Test
Oura’s $15.6 billion IPO asks investors to price a smart ring as a recurring health-data platform. The subscription moat now faces its public-market test.
China’s Robot IPO Pause Turns Revenue Quality Into the Real Test
China is slowing humanoid robot listings as regulators test whether state backed projects prove durable commercial demand or only policy driven growth.
